论文部分内容阅读
本文旨在研究何种睾丸酮(T)制剂是克兰菲特综合征(KS)男性性功能低减的最佳补充治疗。给34例KS患者以下三种T制剂:(1)甲基T(MT)5mg舌下含2次/日。(2)丙酸T(TP)25mg肌注3次/周。(3)复合T(TV,含TP25mg及庚酸T110mg)肌注1次/10日。于用药前后不同时间取血测T、FSH及LH。6例正常男性及13例促性腺激素低减性男性功能低减(HH)作为对照组。
This article aims to investigate which testosterone (T) formulation is the best complementary treatment for men with reduced sexual function in Cranfite Syndrome (KS). Thirty-four patients with KS underwent the following three T preparations: (1) methyl T (MT) 5 mg sublingual for 2 times daily. (2) propionic acid T (TP) 25mg intramuscular 3 times / week. (3) composite T (TV, containing TP25mg and heptanoic acid T110mg) intramuscular injection 1/10. At different times before and after taking blood test T, FSH and LH. 6 normal men and 13 hypogonadal men with hypogonadism (HH) as control group.